Transfusions

Diaspirin Cross-Linked Hemoglobin: A Postsurgical Alternative?

Published in Blood Weekly, May 4th, 2000

Diaspirin cross-linked hemoglobin (DCLHb) can help some patients avoid erythrocyte exposure after cardiac surgery, according to researchers.

M.L. Lamy and colleagues in Belgium examined the efficacy, safety, hemodynamic effects, and plasma persistence of DCLHb as a potential alternative to allogeneic blood transfusions for cardiac surgery patients ("Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery," Anesthesiology, 2000;92(3):646-656).

This study was conducted at several institutions. It was randomized, active-control, and single-blind. The subjects were 209...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-05-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry